Latest Articles
National Weather Service confirms two tornadoes in Louisiana over the weekend - WDSU
National Weather Service confirms two tornadoes in Louisiana over the weekend WDSU
Published: Oct. 27, 2025, 11:25 p.m.
Exploring Iron, Aging, and Fibrosis in Endometriosis - Bioengineer.org
Exploring Iron, Aging, and Fibrosis in Endometriosis Bioengineer.org
Published: Oct. 27, 2025, 11:10 p.m.
BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 10:53 p.m.
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health - MedCity News
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health MedCity News
Published: Oct. 27, 2025, 10:24 p.m.
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study - TipRanks
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study TipRanks
Published: Oct. 27, 2025, 10:21 p.m.
EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis - TipRanks
EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis TipRanks
Published: Oct. 27, 2025, 9:42 p.m.
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic - citybuzz -
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic citybuzz -
Published: Oct. 27, 2025, 9:33 p.m.
Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment - TipRanks
Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 9:13 p.m.
Monday's Health Report: What is endometriosis and how can it affect your life? - WBRZ
Monday's Health Report: What is endometriosis and how can it affect your life? WBRZ
Published: Oct. 27, 2025, 9:02 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal
Published: Oct. 27, 2025, 7:50 p.m.
Link copied to clipboard!